Magee, E. A.; Tasker, S. M.; Edmond, L. M.; Kong, S. C.; Cummings, J. H.
April 2004
Gut;Apr2004 Supplement 3, Vol. 53, pA5
Academic Journal
The cause of ulcerative colitis (UC) is unknown, although the relapsing nature and geographical incidence of the disease implicate environmental factors. Sulphiting agents are widely used food additives. Due to the toxicity of sulphur compounds, intakes of sulphited foods are a possible cause of relapse in UC. Intakes of sulphited foods were associated with increased disease activity in UC. The dietary analysis method used provides a new tool for establishing relationships between diet and disease and a potentially therapeutic diet for UC.


Related Articles

  • Mesalazyna w uzyskiwaniu remisji sluz�wkowej we wrzodziejacym zapaleniu jelita grubego. Albrecht, Piotr; Lazowska-Przeorek, Izabella // Contemporary Pediatrics, Gastroenterology, Hepatology & Child Fe;2012, Vol. 14 Issue 4, p157 

    Ulcerative colitis (UC) is one of the forms of inflammatory bowel diseases (IBD). Achieving a full mucosal healing during the course of treatment improves the patient's quality of life and increases the chances for a sustained remission and a better course of the disease. Mucosal healing reduces...

  • Prognostic Value of Serologic and Histologic Markers on Clinical Relapse in Ulcerative Colitis Patients With Mucosal Healing. Bessissow, Talat; Lemmens, Bart; Ferrante, Marc; Bisschops, Raf; Van Steen, Kristel; Geboes, Karel; Van Assche, Gert; Vermeire, Séverine; Rutgeerts, Paul; De Hertogh, Gert // American Journal of Gastroenterology;Nov2012, Vol. 107 Issue 11, p1684 

    OBJECTIVES:Endoscopic mucosal healing is a key endpoint for the treatment of ulcerative colitis (UC). The role of microscopic activity in predicting disease relapse has not been fully assessed. We aimed to investigate the predictive role of serologic and histologic markers on disease relapse in...

  • Sulfasalazine. Peppercorn, Mark A. // Annals of Internal Medicine;Sep84, Vol. 101 Issue 3, p377 

    Discusses sulfasalazine, a drug that is useful in the treatment of active ulcerative colitis as well as in preventing relapses of the disease in remission. Uncertainty about the mechanism of action of the drug; Agents with possible interaction with sulfasalazine; One limitation of the use of...

  • Oral Mesalamine (Asacol) for Mildly to Moderately Active Ulcerative Colitis. Sninsky, Charles A.; Cort, David H.; Shanahan, Fergus; Powers, Bernard J.; Sessions, John T.; Pruitt, Ronald E.; Jacobs, Walter H.; Lo, Simon K.; Targan, Stephan R.; Cerda, James J.; Gremillion, Daniel E.; Snape, William J.; Sabel, John; Jinich, Horacio; Swinehart, James M.; DeMicco, Michael P. // Annals of Internal Medicine;9/1/91, Vol. 115 Issue 5, p350 

    Presents information on a study that evaluated the efficacy and safety of a pH-sensitive, polymer-coated oral preparation of mesalamine in patients with mildly to moderately active ulcerative colitis. Research methods; Results and discussion on the study; Conclusion.

  • Balsalazide: A Viewpoint by John C. Mansfield. Mansfield, J.C. // Drugs;Jul1998, Vol. 56 Issue 1, p90 

    Comments on the effectiveness of the drug balsalazide on the treatment of ulcerative colitis. Mechanism of action of the drug; Optimal maintenance dosage.

  • Smoking and nicotine in inflammatory bowel disease: good or bad for cytokines? Zijlstra, F. J. // Mediators of Inflammation;Jun98, Vol. 7 Issue 3, p153 

    SMOKING has either a beneficial or harmful effect on the course and recurrence of ulcerative colitis and Crohn's disease respectively. Transdermal application of nicotine had similar effects in ulcerative colitis and therefore was considered to be an effective basic drug which could be further...

  • A clinical trial of combined use of rosiglitazone and 5-aminosalicylate for ulcerative colitis. Hong-Liang Liang; Qin Ouyang // World Journal of Gastroenterology;1/7/2008, Vol. 14 Issue 1, p114 

    AIM: To investigate the therapeutic effects of the combined use of rosiglitazone and aminosalicylate on mild or moderately active ulcerative colitis (UC). METHODS: According to the national guideline for diagnosis and treatment of inflammatory bowel disease (IBD) in China, patients with mild or...

  • Predictors and the Rate of Medical Treatment Failure in Ulcerative Colitis. Chakravarty, B. J. // American Journal of Gastroenterology;Jun1993, Vol. 88 Issue 6, p852 

    Eighty-nine admissions into Auckland Hospital with exacerbation of ulcerative colitis (between May 1985 and May 1991) were analyzed to determine the rate and any predictors of medical treatment failure. Twenty-five patients (28%) failed to respond to medical treatment and required surgery....

  • Green Tea Extract for Ulcerative Colitis. Gaby, Alan R. // Townsend Letter;Jun2014, Issue 371, p32 

    The article focuses on a study which examined the administration of Polyphenon E, a green tea extract, on patients with mild-to-moderate ulcerative colitis who had failed to respond to 5-aminosalicylic acid and/or azathioprine.


Read the Article


Sign out of this library

Other Topics